No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy

The risk for gastrointestinal bleeding from dual antiplatelet therapy (DAPT) with new antiplatelets (prasugrel/ticagrelor) compared to clopidogrel is unclear. Aim: To determine the risk and type of major (gastrointestinal bleeding requiring hospitalization) and minor (anemia and iron deficiency) gas...

Full description

Bibliographic Details
Main Authors: Viviana Laredo, Pablo Revilla-Marti, Carlos Sostres, Sandra García, Patricia Carrera-Lasfuentes, Ángel Lanas
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
ticagrelor
prasugrel
gastrointestinal bleeding
dual antiplatelet therapy
Online Access:https://www.mdpi.com/2077-0383/9/5/1526

Internet

https://www.mdpi.com/2077-0383/9/5/1526

Similar Items